PAH Breakthrough: New Therapy Extends Survival Rates
Pulmonary Hypertension Treatment: A Future Shaped by Personalized Therapies and Early Detection Imagine a future where a diagnosis of pulmonary arterial hypertension (PAH) isn’t a life sentence, but a manageable condition with significantly extended life expectancy. Recent clinical trial results suggest this future is closer than we think. The groundbreaking IMPRES study, showcasing the dramatic … Read more